We serve Chemical Name:2-(5-tert-butyl-2-phenylmethoxyphenyl)-2-methylpropanenitrile CAS:1246213-27-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(5-tert-butyl-2-phenylmethoxyphenyl)-2-methylpropanenitrile
CAS.NO:1246213-27-3
Synonyms:2-(5-tert-butyl-2-phenylmethoxyphenyl)-2-methylpropanenitrile
Molecular Formula:C21H25NO
Molecular Weight:307.42900
HS Code:2926909090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:33.02000
Exact Mass:307.19400
LogP:5.36428
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-(5-tert-butyl-2-phenylmethoxyphenyl)-2-methylpropanenitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(5-tert-butyl-2-phenylmethoxyphenyl)-2-methylpropanenitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(5-tert-butyl-2-phenylmethoxyphenyl)-2-methylpropanenitrile Use and application,2-(5-tert-butyl-2-phenylmethoxyphenyl)-2-methylpropanenitrile technical grade,usp/ep/jp grade.
Related News: As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company��s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations. 2-(5-tert-butyl-2-phenylmethoxyphenyl)-2-methylpropanenitrile manufacturer As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company��s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations. 2-(5-tert-butyl-2-phenylmethoxyphenyl)-2-methylpropanenitrile supplier Lilly has denied retaliating against any employees, and no lawsuit has been filed on behalf of Mula. 2-(5-tert-butyl-2-phenylmethoxyphenyl)-2-methylpropanenitrile vendor Lilly has denied retaliating against any employees, and no lawsuit has been filed on behalf of Mula. 2-(5-tert-butyl-2-phenylmethoxyphenyl)-2-methylpropanenitrile factory Using a proprietary chemistry platform, Onconova has created a pipeline of targeted agents designed to work against specific cellular pathways that are important in cancer cells.
